Paper41008790
Influence of Genetic, Dietary, and Environmental Factors on Natural Killer (NK) Cell Biology and Function: Interplay Between NK Cell Activity and Cancer Onset or Progression.
Kaur K. Cancers (Basel), 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Influence of Genetic, Dietary, and Environmental Factors on Natural Killer (NK) Cell Biology and Function: Interplay Between NK Cell Activity and Cancer Onset or Progression. Papers, record 41008790. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41008790
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Influence of Genetic, Dietary, and Environmental Factors on Natural Killer (NK) Cell Biology and Function: Interplay Between NK Cell Activity and Cancer Onset or Progression.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References249
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34824036 | Crosstalk between macrophages and natural killer cells in the tumor microenvironment. | Int Immunopharmacol | 2021 | https://conductscience.org/library/papers/34824036 | PubMed |
| 2 | 33266177 | Immunomodulatory Effects of IL-2 and IL-15; Implications for Cancer Immunotherapy. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33266177 | PubMed |
| 3 | 21187373 | Revisiting human natural killer cell subset function revealed cytolytic CD56(dim)CD16+ NK cells as rapid producers of abundant IFN-gamma on activation. | Proc Natl Acad Sci U S A | 2011 | https://conductscience.org/library/papers/21187373 | PubMed |
| 4 | 34559307 | Defective NK cell expansion, cytotoxicity, and lack of ability to differentiate tumors from a pancreatic cancer patient in a long term follow-up: implication in the progression of cancer. | Cancer Immunol Immunother | 2022 | https://conductscience.org/library/papers/34559307 | PubMed |
| 5 | 11117911 | Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. | Lancet | 2000 | https://conductscience.org/library/papers/11117911 | PubMed |
| 6 | 37828009 | Perinatal murine cytomegalovirus infection reshapes the transcriptional profile and functionality of NK cells. | Nat Commun | 2023 | https://conductscience.org/library/papers/37828009 | PubMed |
| 7 | 40088447 | The tumor microenvironment is an ecosystem sustained by metabolic interactions. | Cell Rep | 2025 | https://conductscience.org/library/papers/40088447 | PubMed |
| 8 | 40119192 | Enhancing human NK cell antitumor function by knocking out SMAD4 to counteract TGFβ and activin A suppression. | Nat Immunol | 2025 | https://conductscience.org/library/papers/40119192 | PubMed |
| 9 | 26806484 | Natural killer cell memory in infection, inflammation and cancer. | Nat Rev Immunol | 2016 | https://conductscience.org/library/papers/26806484 | PubMed |
| 10 | 29748898 | Cystatin F as a regulator of immune cell cytotoxicity. | Cancer Immunol Immunother | 2018 | https://conductscience.org/library/papers/29748898 | PubMed |
| 11 | 25054077 | Utilizing cytokines to function-enable human NK cells for the immunotherapy of cancer. | Scientifica (Cairo) | 2014 | https://conductscience.org/library/papers/25054077 | PubMed |
| 12 | 19239902 | The many roles of FAS receptor signaling in the immune system. | Immunity | 2009 | https://conductscience.org/library/papers/19239902 | PubMed |
| 13 | 37341510 | NK Cells from Human Cytomegalovirus-Seropositive Individuals Have a Distinct Metabolic Profile That Correlates with Elevated mTOR Signaling. | J Immunol | 2023 | https://conductscience.org/library/papers/37341510 | PubMed |
| 14 | 33440654 | ADCC against MICA/B Is Mediated against Differentiated Oral and Pancreatic and Not Stem-Like/Poorly Differentiated Tumors by the NK Cells; Loss in Cancer Patients due to Down-Modulation of CD16 Receptor. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33440654 | PubMed |
| 15 | 16609008 | Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive natural killer cells. | Clin Cancer Res | 2006 | https://conductscience.org/library/papers/16609008 | PubMed |
| 16 | 19344420 | Replicative potential of human natural killer cells. | Br J Haematol | 2009 | https://conductscience.org/library/papers/19344420 | PubMed |
| 17 | 32269968 | Memory and Memory-Like NK Cell Responses to Microbial Pathogens. | Front Cell Infect Microbiol | 2020 | https://conductscience.org/library/papers/32269968 | PubMed |
| 18 | 29605760 | Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering. | Curr Opin Immunol | 2018 | https://conductscience.org/library/papers/29605760 | PubMed |
| 19 | 32612110 | CD96, a new immune checkpoint, correlates with immune profile and clinical outcome of glioma. | Sci Rep | 2020 | https://conductscience.org/library/papers/32612110 | PubMed |
| 20 | 32272610 | Mechanisms of Resistance to NK Cell Immunotherapy. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32272610 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41008790
GET https://conductscience.org/api/papers/v1/41008790/references?page=2